AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Offer a clear, concise explanation of what an index fund is, how it works, and what investors should consider when using them.
13,305 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
BitGo's latest move adds to the crypto job-cut trend as it slashes about 15% of its workforce to refocus on stablecoi...
Keel Infrastructure surged as it secured a large convertible financing to fuel AI data centers. This article breaks d...
Coastal thefts show a chilling pattern: suspects watching surfers hide keys, then using stolen info to raid cars and ...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
SpaceX is counting down to a defining moment within two weeks. This guide explains what the milestone could mean for ...
MicroStrategy announces a sweeping Digital Credit Capital Framework that reshapes how it funds Bitcoin purchases and ...
AT&T and Verizon report Q1 2026 results as fiber deals reshape their paths. This analysis weighs dividends, cash flow...
US spot Bitcoin ETFs posted a tough week, with persistent outflows until July 2 when buyers returned briefly. Ethereu...
Income investors are eyeing bristol myers squibb's 4.3% yield, but a high payout begs questions about safety. This ar...
As 2026 retirement limits rise, owner-operators may qualify for a far larger Solo 401(k) than company drivers using a...
On a volatile trading day, fuelcell energy stock tumbling becomes a talking point for traders and long-term holders a...